A highlight of the meeting was the lecture delivered by John Denstedt, “RIRS vs Mini PCNL for Renal Stones: Which Will Win the Race?”, he emphasized that miniaturized approaches can achieve stone-free rates comparable to PCNL, while offering lower bleeding risk, less postoperative pain, and shorter hospital stays.

During two hands-on training sessions, participants experienced HugeMed’s 6.3Fr ureteroscope firsthand. Many highlighted its smooth access and potential to minimize patient trauma, sparking valuable discussions on contemporary stone management.

Thank you for being part of this journey. Together, we are shaping the next chapter of endourology in the Americas.